{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:14:42Z","timestamp":1778886882207,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.heliyon.2024.e29447","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T12:29:37Z","timestamp":1712665777000},"page":"e29447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Anticancer potential of grifolin in lung cancer treatment through PI3K\/AKT pathway inhibition"],"prefix":"10.1016","volume":"10","author":[{"given":"Li","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zexu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huayong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuqi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongliang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8370-2977","authenticated-orcid":false,"given":"Bing","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.heliyon.2024.e29447_bib1","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","article-title":"Cancer statistics in China and United States, 2022: profiles, trends, and determinants","volume":"135","author":"Xia","year":"2022","journal-title":"Chin. Med. J."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e29447_bib2","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.20892\/j.issn.2095-3941.2022.0231","article-title":"Current cancer burden in China: epidemiology, etiology, and prevention","volume":"19","author":"Maomao","year":"2022","journal-title":"Cancer Biol Med"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e29447_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14061404","article-title":"Impact of proton pump inhibitors and histamine-2-receptor antagonists on non-small cell lung cancer immunotherapy: a systematic review and meta-analysis","volume":"14","author":"Rizzo","year":"2022","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e29447_bib4","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/s41416-022-01929-w","article-title":"Identifying optimal first-line treatment for advanced non-small cell lung carcinoma with high PD-L1 expression: a matter of debate","volume":"127","author":"Rizzo","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"103596","key":"10.1016\/j.heliyon.2024.e29447_bib5","first-page":"12","article-title":"The impact of gender on the efficacy of immune checkpoint inhibitors in cancer patients: the MOUSEION-01 study","volume":"170","author":"Santoni","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e29447_bib6","doi-asserted-by":"crossref","first-page":"5039","DOI":"10.1007\/s10238-023-01159-1","article-title":"The impact of ECOG performance status on efficacy of immunotherapy and immune-based combinations in cancer patients: the MOUSEION-06 study","volume":"23","author":"Mollica","year":"2023","journal-title":"Clin. Exp. Med."},{"issue":"16","key":"10.1016\/j.heliyon.2024.e29447_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168661","article-title":"Current and future development in lung cancer diagnosis","volume":"22","author":"Nooreldeen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e29447_bib8","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.mayocp.2019.01.013","article-title":"Non-Small cell lung cancer: epidemiology, screening, diagnosis, and treatment","volume":"94","author":"Duma","year":"2019","journal-title":"Mayo Clin. Proc."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e29447_bib9","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/jjco\/hyg083","article-title":"Influence of clinical parameters on quality of life during chemotherapy in patients with advanced non-small cell lung cancer: application of a general linear model","volume":"33","author":"Morita","year":"2003","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.heliyon.2024.e29447_bib10","first-page":"67","article-title":"Targeting AXL in NSCLC","volume":"12","author":"Zaman","year":"2021","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e29447_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/nu12051339","article-title":"Antitumor, anti-inflammatory and antiallergic effects of agaricus blazei mushroom extract and the related medicinal basidiomycetes mushrooms, hericium erinaceus and grifola frondosa: a review of preclinical and clinical studies","volume":"12","author":"Hetland","year":"2020","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29447_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12094-020-02428-1","article-title":"Recent findings on the role of fungal products in the treatment of cancer","volume":"23","author":"Shamsaei","year":"2021","journal-title":"Clin. Transl. Oncol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e29447_bib13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/1534735415572883","article-title":"Polysaccharide K and Coriolus versicolor extracts for lung cancer: a systematic review","volume":"14","author":"Fritz","year":"2015","journal-title":"Integr. Cancer Ther."},{"issue":"2\u20133","key":"10.1016\/j.heliyon.2024.e29447_bib14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejphar.2011.08.026","article-title":"DAPK1 mediates the G1 phase arrest in human nasopharyngeal carcinoma cells induced by grifolin, a potential antitumor natural product","volume":"670","author":"Luo","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29447_bib15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ejca.2010.09.021","article-title":"Grifolin, a potent antitumour natural product upregulates death-associated protein kinase 1 DAPK1 via p53 in nasopharyngeal carcinoma cells","volume":"47","author":"Luo","year":"2011","journal-title":"Eur. J. Cancer"},{"issue":"13","key":"10.1016\/j.heliyon.2024.e29447_bib16","doi-asserted-by":"crossref","first-page":"21454","DOI":"10.18632\/oncotarget.15250","article-title":"Grifolin exhibits anti-cancer activity by inhibiting the development and invasion of gastric tumor cells","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e29447_bib17","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s10495-007-0062-z","article-title":"Grifolin induces apoptosis via inhibition of PI3K\/AKT signalling pathway in human osteosarcoma cells","volume":"12","author":"Jin","year":"2007","journal-title":"Apoptosis"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29447_bib18","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3892\/or.2016.4840","article-title":"Grifolin induces autophagic cell death by inhibiting the Akt\/mTOR\/S6K pathway in human ovarian cancer cells","volume":"36","author":"Che","year":"2016","journal-title":"Oncol. Rep."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e29447_bib19","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.7150\/jca.84030","article-title":"miR-21-5p inhibits the proliferation, migration, and invasion of glioma by targeting S100A10","volume":"14","author":"Gao","year":"2023","journal-title":"J. Cancer"},{"key":"10.1016\/j.heliyon.2024.e29447_bib20","article-title":"Tizoxanide promotes apoptosis in glioblastoma by inhibiting CDK1 activity","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"964816","key":"10.1016\/j.heliyon.2024.e29447_bib21","article-title":"Anti-cancer properties of Caulerpa racemosa by altering expression of Bcl-2, BAX, cleaved caspase 3 and apoptosis in HeLa cancer cell culture","volume":"12","author":"Permatasari","year":"2022","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e29447_bib22","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1158\/1055-9965.EPI-19-0221","article-title":"Cancer progress and priorities: lung cancer","volume":"28","author":"Schabath","year":"2019","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"375","key":"10.1016\/j.heliyon.2024.e29447_bib23","article-title":"Advances in systemic therapy for non-small cell lung cancer","volume":"9","author":"Miller","year":"2021","journal-title":"Bmj"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29447_bib24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12885-019-6054-x","article-title":"Patient preferences of chemotherapy treatment options and tolerance of chemotherapy side effects in advanced stage lung cancer","volume":"19","author":"Islam","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.heliyon.2024.e29447_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.semcancer.2020.03.004","article-title":"Regulation of cancer cell signaling pathways as key events for therapeutic relevance of edible and medicinal mushrooms","volume":"80","author":"Neergheen","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29447_bib26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jcmm.13564","article-title":"Molecular basis for Poria cocos mushroom polysaccharide used as an antitumour drug in China","volume":"23","author":"Li","year":"2019","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29447_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27010284","article-title":"Pharmacological effects of grifolin: focusing on anticancer mechanisms","volume":"27","author":"Bouyahya","year":"2022","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29447_bib28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.canlet.2007.09.001","article-title":"Grifolin, a potential antitumor natural product from the mushroom Albatrellus confluens, induces cell-cycle arrest in G1 phase via the ERK1\/2 pathway","volume":"258","author":"Ye","year":"2007","journal-title":"Cancer Lett."},{"issue":"16","key":"10.1016\/j.heliyon.2024.e29447_bib29","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1016\/j.febslet.2005.05.013","article-title":"Grifolin, a potential antitumor natural product from the mushroom Albatrellus confluens, inhibits tumor cell growth by inducing apoptosis in vitro","volume":"579","author":"Ye","year":"2005","journal-title":"FEBS Lett."},{"issue":"40","key":"10.1016\/j.heliyon.2024.e29447_bib30","doi-asserted-by":"crossref","first-page":"42704","DOI":"10.18632\/oncotarget.5678","article-title":"Grifolin directly targets ERK1\/2 to epigenetically suppress cancer cell metastasis","volume":"6","author":"Luo","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29447_bib31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/jfbc.14021","article-title":"Anti-cancer effect of astrakurkurol from a folklore tribal mushroom on human hepatocellular carcinoma cells via mediating cell cycle inhibition, apoptosis, and migration","volume":"46","author":"Nandi","year":"2022","journal-title":"J. Food Biochem."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29447_bib32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4162\/nrp.2015.9.2.111","article-title":"Ethanol extract of Innotus obliquus (Chaga mushroom) induces G1 cell cycle arrest in HT-29 human colon cancer cells","volume":"9","author":"Lee","year":"2015","journal-title":"Nutr. Res. Prac."},{"issue":"23","key":"10.1016\/j.heliyon.2024.e29447_bib33","doi-asserted-by":"crossref","first-page":"10165","DOI":"10.1007\/s00253-020-10918-z","article-title":"Latcripin-7A, derivative of Lentinula edodes C(91-3), reduces migration and induces apoptosis, autophagy, and cell cycle arrest at G(1) phase in breast cancer cells","volume":"104","author":"Din","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29447_bib34","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41418-020-00648-0","article-title":"Ubiquitin signaling in cell cycle control and tumorigenesis","volume":"28","author":"Dang","year":"2021","journal-title":"Cell Death Differ."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e29447_bib35","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1007\/s12094-022-03067-4","article-title":"Therapeutic effects of hAMSCs secretome on proliferation of MDA-MB-231 breast cancer cells by the cell cycle arrest in G1\/S phase","volume":"25","author":"Rahimi Lifshagerd","year":"2023","journal-title":"Clin. Transl. Oncol."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e29447_bib36","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1158\/0008-5472.CAN-17-3024","article-title":"Cotargeting BCL-2 and PI3K induces BAX-dependent mitochondrial apoptosis in AML cells","volume":"78","author":"Rahmani","year":"2018","journal-title":"Cancer Res."},{"issue":"sup2","key":"10.1016\/j.heliyon.2024.e29447_bib37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/21691401.2018.1452750","article-title":"Silver nanoparticles Clinacanthus Nutans leaves extract induced apoptosis towards oral squamous cell carcinoma cell lines","volume":"46","author":"Yakop","year":"2018","journal-title":"Artif. Cells, Nanomed. Biotechnol."},{"issue":"3\u20134","key":"10.1016\/j.heliyon.2024.e29447_bib38","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s10495-019-01515-1","article-title":"Chemotherapeutic paclitaxel and cisplatin differentially induce pyroptosis in A549 lung cancer cells via caspase-3\/GSDME activation","volume":"24","author":"Zhang","year":"2019","journal-title":"Apoptosis"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e29447_bib39","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.3892\/ol.2017.6092","article-title":"Grifolin induces apoptosis and promotes cell cycle arrest in the A2780 human ovarian cancer cell line via inactivation of the ERK1\/2 and Akt pathways","volume":"13","author":"Yan","year":"2017","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29447_bib40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s10020-022-00489-2","article-title":"UBE2S promotes the development of ovarian cancer by promoting PI3K\/AKT\/mTOR signaling pathway to regulate cell cycle and apoptosis","volume":"28","author":"Zhang","year":"2022","journal-title":"Mol Med"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29447_bib41","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s12032-022-01883-w","article-title":"ITF2357 induces cell cycle arrest and apoptosis of meningioma cells via the PI3K-Akt pathway","volume":"40","author":"Zhang","year":"2022","journal-title":"Med. Oncol."},{"key":"10.1016\/j.heliyon.2024.e29447_bib42","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.gene.2019.02.076","article-title":"The relation between PI3K\/AKT signalling pathway and cancer","volume":"698","author":"Noorolyai","year":"2019","journal-title":"Gene"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29447_bib43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","article-title":"PI3K\/Akt signalling pathway and cancer","volume":"30","author":"Fresno Vara","year":"2004","journal-title":"Cancer Treat Rev."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e29447_bib44","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/1759-7714.13328","article-title":"Targeting the PI3K\/Akt\/mTOR pathway in non-small cell lung cancer (NSCLC)","volume":"11","author":"Tan","year":"2020","journal-title":"Thorac Cancer"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e29447_bib45","article-title":"Phase II study of taselisib in PIK3CA-mutated solid tumors other than breast and squamous lung cancer: results from the NCI-match ECOG-ACRIN trial (EAY131) subprotocol I","volume":"6","author":"Krop","year":"2022","journal-title":"JCO Precis Oncol"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29447_bib46","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41598-021-93815-3","article-title":"PTEN loss promotes oncogenic function of STMN1 via PI3K\/AKT pathway in lung cancer","volume":"11","author":"Xun","year":"2021","journal-title":"Sci. Rep."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024054781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024054781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:36:43Z","timestamp":1778884603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024054781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2405844024054781"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29447","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticancer potential of grifolin in lung cancer treatment through PI3K\/AKT pathway inhibition","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29447","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e29447"}}